N. E. Kemeny
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 14
- Colorectal Cancer Treatments and Studies 8
- Cancer Treatment and Pharmacology 5
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Co-authors
- Leonard B. Saltz (4 shared papers)A. M. Cohen (2 shared papers)David P. Kelsen (1 shared paper)Bruce D. Minsky (1 shared paper)Elin R. Sigurdson (1 shared paper)Joanne Frankel (1 shared paper)Bonnie Reichman (1 shared paper)Warren E. Enker (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)European Journal of Cancer (1 paper)Value in Health (1 paper)Clinical & Experimental Metastasis (1 paper)Seminars in Radiation Oncology (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
N. E. Kemeny
24 papers receiving 525 citations
Peers
Comparison fields: 5 of 45
- Oncology 375
- Hepatology 107
- Pulmonary and Respiratory Medicine 117
- Surgery 127
- Pathology and Forensic Medicine 46
Countries citing papers authored by N. E. Kemeny
This map shows the geographic impact of N. E. Kemeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. E. Kemeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. E. Kemeny more than expected).
Fields of papers citing papers by N. E. Kemeny
This network shows the impact of papers produced by N. E. Kemeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. E. Kemeny. The network helps show where N. E. Kemeny may publish in the future.
Co-authors
The 25 scholars most cited alongside N. E. Kemeny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 179 | |
| 2 | 2005 | 148 | |
| 3 | 2012 | 40 | |
| 4 | Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes! | 1992 | 30 |
| 5 | Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver. | 1996 | 26 |
| 6 | 1996 | 22 | |
| 7 | 2005 | 16 | |
| 8 | Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver. | 1996 | 14 |
| 9 | Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder. | 1978 | 14 |
| 10 | Therapy of colorectal hepatic metastases. | 1986 | 13 |
| 11 | 2010 | 9 | |
| 12 | Modulation of fluorouracil by N-(phosphonacetyl)-L-asparate: a review. | 1992 | 9 |
| 13 | Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma. | 1982 | 8 |
| 14 | Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma. | 1984 | 8 |
| 15 | 1991 | 4 | |
| 16 | 2008 | 4 | |
| 17 | Overview of N-(phosphonacetyl)-L-aspartate + fluorouracil in clinical trials. | 1992 | 4 |
| 18 | 2005 | 2 | |
| 19 | 2008 | 2 | |
| 20 | Phase II trial of bisantrene in advanced colorectal carcinoma. | 1983 | 2 |
About N. E. Kemeny
N. E. Kemeny is a scholar working on Oncology, Hepatology, Surgery, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 24 papers that have together received 559 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Gastric Cancer Management and Outcomes (3 papers), Renal cell carcinoma treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (375 citations), Hepatology (107 citations), Pulmonary and Respiratory Medicine (117 citations), Surgery (127 citations) and Pathology and Forensic Medicine (46 citations). N. E. Kemeny has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Leonard B. Saltz, A. M. Cohen, David P. Kelsen, Bruce D. Minsky, Elin R. Sigurdson, Joanne Frankel, Bonnie Reichman, Warren E. Enker, Ellen Hollywood and Paul Hoff. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Value in Health, Clinical & Experimental Metastasis and Seminars in Radiation Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.